Clinical TrialID 6723
Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant
NCT01593215
Type 2 Diabetes
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6723
- Evidence Id
- 6723
- Core Evidence Id
- 6723
- Source Clinical Trial Id
- 6710
- Herb2 Clinical Trial Id
- HBCT006710
- Nct Id
- NCT01593215
- Title
- Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant
- Status
- Completed
- Phase
- Phase 2
- Study Result
- Yes
- Study Condition
- Type 2 Diabetes
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Yohimbine
- Intervention Allocation
- Randomized
- Intervention Model
- Crossover
- Intervention Mask
- Quadruple
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 50
- Outcome Measure
- Insulin Secretion, insulin secretion will be measured (nMole) in response to an oral glucose tolerance test. Patients will receive the capsules 1 h before the glucose test, and the insulin levels 30 minutes after the oral glucose will be used as a primary outcome measure. The insulin levels at the highest tolerated dose of yohimbine will be used., 30 minutes after oral glucose
- Sponsor Collaborator
- Anders Rosengren, MD PhD|Region Skane|Lund University
- Funded By
- OTHER
- Location
- Skanes Universitetssjukhus, Malmo, Skane, 20502, Sweden
- Other Id
- 2010-018604-85
- Start Date
- 2012-05
- Primary Completion Date
- 2014-10
- Completion Date
- 2014-10
- First Posted
- 2012-05-08
- Results First Posted
- 2015-01-09
- Last Update Posted
- 2015-01-09
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01593215
- Title Cn
- Title En
- Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk Variant
- Bilingual Status
- semi_complete